FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely to compositions for preventing or treating symptoms associated with a gastrointestinal disorder. Disclosed is a composition for preventing or treating symptoms associated with a gastrointestinal disorder, comprising bacterial species that are purified, and wherein the bacterial species include at least one short-chain fatty acid (SCFA) producing bacterial species, and at least one SCFA-metabolising bacterial species, where when the composition is cultured in an acidic medium at pH 6–8 and conditions with low oxygen content of up to 8 g/l, at least one SCFA-producing bacterial species is present in an amount, sufficient to provide an amount of SCFA sufficient to maintain the growth of at least one SCFA-metabolizing bacteria. Composition for preventing or treating symptoms associated with a gastrointestinal disorder, containing types of bacteria, which are purified and are in suspension, is characterized by the above composition. Composition for preventing or treating symptoms associated with a gastrointestinal disorder differs from the above in that it is in powder form.
EFFECT: said group of inventions is suitable for preventing or treating symptoms associated with a gastrointestinal disorder.
26 cl, 12 dwg, 2 tbl, 3 ex
Title |
Year |
Author |
Number |
USE OF MICROBIAL COMMUNITIES FOR THE TREATMENT OF HUMANS AND ANIMALS |
2017 |
- Posseme Sem
- Marzorati Massimo
- Van De Vile Tom
- Skhejrlink Ilse
- Van Den Abele Piter
- Bolka Selin
- Gottardi David
|
RU2758387C2 |
USE OF COMPOSITIONS CONTAINING BIFIDOBACTERIUM ANIMALIS SSP. LACTIS LMG P-28149 |
2015 |
- Kentan Zhoan
- Linart Van Lidt De Jede Ekhan
- Granzhett Korinn
- Po Bryuno
- Makki Kassem
- Volevchuk Izabell
- Alar Zhann
- Lerter-Valanti Veronik
|
RU2673341C2 |
USE OF CAROTENOID OF MICROBIAL ORIGIN THAT AFFECTS COMPOSITION OF INTESTINAL MICROORGANISMS |
2017 |
- Possemiers, Sam
- Duysburgh, Cindy
- Pinheiro, Iris
- Bolca, Selin
- Van Den Abbeele, Pieter
- Marzorati, Massimo
|
RU2759600C2 |
COMPOSITIONS AND METHODS FOR INCREASING OR MAINTAINING ABUNDANCE OF FAECALIBACTERIUM PRAUSNITZII |
2015 |
- Derrien, Muriel
- Lebas, Mathilde
- Garault, Peggy
|
RU2712568C2 |
COMPOSITIONS AND METHODS FOR PREVENTING AND/OR TREATING VITAMIN B12 DEFICIENCY |
2017 |
|
RU2730870C2 |
PREBIOTIC FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH DISTURBED COMPOSITION OR FUNCTIONALITY OF THE INTESTINAL MICROBIOME |
2018 |
- Albers, Ruud
- Tzoumaki, Maria
|
RU2799081C2 |
METHODS FOR IMPROVING BLOCKADE THERAPY OF IMMUNE CHECKPOINTS THROUGH MICROBIOME MODULATION |
2017 |
- Vargo, Dzhennifer
- Gopalakrishnan, Vanchesvaran
|
RU2793582C2 |
FAECALIBACTERIUM PRAUSNITZII AND DESULFOVIBRIO PIGER FOR USE IN TREATMENT OR PREVENTION OF DIABETES AND INTESTINAL DISEASES |
2016 |
- Khan Muhammad-Tanweer
- Backhed Fredrik
|
RU2754367C2 |
PREBIOTIC COMPOSITION AND ITS USE |
2020 |
- Morrison, Neil, A.
- Yu, Hailong
- Abdou, John, P.
- Manjunatha, Narayana, Murthy
- Talashek, Todd, A.
|
RU2808430C2 |
FAECALIBACTERIUM PRAUSNITZII AND DESULFOVIBRIO PIGER FOR USE IN THE TREATMENT OR PREVENTION OF DIABETES AND INTESTINAL DISEASES |
2016 |
- Kkhan, Mukhammad-Tanvir
- Bekkhed, Fredrik
|
RU2797466C2 |